Dockets

Federal rulemakings, soonest-closing first — each gathers its documents and comments.

NonrulemakingFDA

Implementation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009

1
document
4.7K
comments
Last activity Jul 30, 2026View docket →
NonrulemakingFDA

Requests that the Food and Drug Administration issue a written determination regarding the regulatory status of fluoride compounds distributed for community water fluoridation

9
documents
8
comments

1 awaiting analysis

Last activity Jul 30, 2026View docket →
NonrulemakingFDA

Requests that the FDA Open a Docket, Hold a Part 15 Public Hearing Regarding the Off-Label Use of Estrogen in Natal Males for Gender Affirmation, and Consider Regulatory Action Including a Boxed Warning Under 21 C.F.R. § 201.80(e)

2
documents
10K
comments

20 awaiting analysis

Last activity Jul 29, 2026View docket →
NonrulemakingFDA

Request that the FDA, acting through its Center for Veterinary Medicine ("CVM"), exercise its post-approval oversight authority to impose enforceable safe-use conditions for Librela (bedinvetmab injection) (NADA 141-562), a caninized monoclonal antibody approved for the control of pain associated with osteoarthritis in dogs

34
documents
385
comments

7 awaiting analysis

Last activity Jul 28, 2026View docket →
NonrulemakingFDA

Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Draft Guidance for Industry; Availability

1
document
1
comments
Last activity Jul 27, 2026View docket →
NonrulemakingFDA

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form for the reasons set forth below and in the Mifepristone Multistate Citizen Petition (FDA-2025-P-1576)

1
document
19
comments

1 awaiting analysis

Last activity Jul 27, 2026View docket →
NonrulemakingFDA

Requests that the FDA initiate rulemaking to switch ivermectin oral tablet products from prescription-only status to full over-the-counter status.

1
document
1.4K
comments

12 awaiting analysis

Last activity Jul 25, 2026View docket →
NonrulemakingFDA

Requests that the FDA initiate rulemaking to switch hydroxychloroquine sulfate (HCQ) oral tablet products from prescription-only status to full over-the-counter status.

1
document
331
comments

1 awaiting analysis

Last activity Jul 25, 2026View docket →
NonrulemakingFAA

Regional Airline Association - Exemption/Rulemaking

4
documents
21
comments
Last activity Jul 23, 2026View docket →
NonrulemakingFDA

How to Prepare a Pre-Request for Designation (Pre-RFD); Availability

1
document
2
comments

1 awaiting analysis

Last activity Jul 23, 2026View docket →
NonrulemakingFDA

Request that the FDA to revoke all BLA’s for every mRNA COVID-19 vaccine for all demographic groups because manufacturers do not and have never met BLA standards

2
documents
4.8K
comments
Last activity Jul 21, 2026View docket →
RulemakingFWS

Endangered and Threatened Wildlife and Plants; 90-Day Findings; Goose Lake sucker

4
documents
1
comments
Last activity Jul 21, 2026View docket →